Sildenafil Tablet
Product Images NDC 68071-2602
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Sildenafil Figure 1)
Sildenafil_fig2 (Sildenafil Figure 2)
Figure3 (Sildenafil Figure 3)
This is a table showing how different drugs interact with Acenocoumarol. It includes information on their impact on parameters such as INR AUC, INR Cmax, and BT. The table also provides recommendations on whether any dose adjustment is needed when these drugs are coadministered with Acenocoumarol. Some drugs are not recommended to be used in combination with Acenocoumarol.*
Figure4 (Sildenafil Figure 4)
Figure5 (Sildenafil Figure 5)
This appears to be a chart or graph showing data related to the usage of placebo and sildenafil 20mg TID for patients with Pulmonary Arterial Hypertension (PAH). Baseline walk distances, patient demographics, and PAH etiology are also included in the chart. However, without proper formatting and context, it is not clear what the numbers and abbreviations represent.*
Figure6 (Sildenafil Figure 6)
Sildenafil-figure-7 (Sildenafil Figure 7)
Structure (Sildenafil Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.